These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19218)

  • 61. An experimental model for the study of hepatic transport and metabolism of toxic compounds.
    Schwenk M; López del Pino V; Remmer H
    Arch Toxicol Suppl; 1979; (2):339-43. PubMed ID: 111647
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The solubility of 2,2',4,4',5,5'-hexachlorobiphenyl in heparinized blood and plasma and in solutions of different plasma components.
    Willebrand T; Kihlström I
    Acta Pharmacol Toxicol (Copenh); 1985 Mar; 56(3):228-32. PubMed ID: 2409743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diffusion and partitioning of hexachlorobiphenyl in sediments.
    Di Toro DM; Jeris JS; Ciarcia D
    Environ Sci Technol; 1985 Dec; 19(12):1169-76. PubMed ID: 22280132
    [No Abstract]   [Full Text] [Related]  

  • 64. Role of Physiologically Based Kinetic modelling in addressing environmental chemical mixtures - A review.
    Desalegn A; Bopp S; Asturiol D; Lamon L; Worth A; Paini A
    Comput Toxicol; 2019 May; 10():158-168. PubMed ID: 31218267
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Physiologically based pharmacokinetic modeling of tea catechin mixture in rats and humans.
    Law FCP; Yao M; Bi HC; Lam S
    Pharmacol Res Perspect; 2017 Jun; 5(3):e00305. PubMed ID: 28603626
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors.
    Walker DM; Kermath BA; Woller MJ; Gore AC
    Endocrinology; 2013 Jun; 154(6):2129-43. PubMed ID: 23592748
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Application of physiologically based pharmacokinetic models in chemical risk assessment.
    Mumtaz M; Fisher J; Blount B; Ruiz P
    J Toxicol; 2012; 2012():904603. PubMed ID: 22523493
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A review of the applications of physiologically based pharmacokinetic modeling.
    Himmelstein KJ; Lutz RJ
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):127-45. PubMed ID: 20218010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.
    Verner MA; Charbonneau M; López-Carrillo L; Haddad S
    Environ Health Perspect; 2008 Jul; 116(7):886-92. PubMed ID: 18629310
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetics and toxicity of idarubicin in the rat.
    Kuhlmann O; Hofmann S; Weiss M
    Eur J Drug Metab Pharmacokinet; 2001; 26(4):215-9. PubMed ID: 11808862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.
    Blakey GE; Nestorov IA; Arundel PA; Aarons LJ; Rowland M
    J Pharmacokinet Biopharm; 1997 Jun; 25(3):277-312. PubMed ID: 9474530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Species-specific pharmacokinetics of styrene in rat and mouse.
    Filser JG; Schwegler U; Csanády GA; Greim H; Kreuzer PE; Kessler W
    Arch Toxicol; 1993; 67(8):517-30. PubMed ID: 8285850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.
    Krewski D; Withey JR; Ku LF; Andersen ME
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):37-50. PubMed ID: 7737040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Controlled release of tetracycline--III: A physiological pharmacokinetic model of the pregnant rat.
    Olanoff LS; Anderson JM
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):599-620. PubMed ID: 7229911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):297-316. PubMed ID: 7175701
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.
    Igari Y; Sugiyama Y; Awazu S; Hanano M
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):53-75. PubMed ID: 7069578
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.
    Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):577-93. PubMed ID: 6678311
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative studies on distribution and covalent tissue binding of 2,4,2',4'- and 3,4,3',4'-tetrachlorobiphenyl isomers in the rat.
    Shimada T; Sawabe Y
    Arch Toxicol; 1984 Sep; 55(3):182-5. PubMed ID: 6437376
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polychlorobiphenyl (PCB) congeners, p,p'-DDE, and hexachlorobenzene in maternal and fetal cord blood from mothers in Upstate New York.
    Bush B; Snow J; Koblintz R
    Arch Environ Contam Toxicol; 1984 Sep; 13(5):517-27. PubMed ID: 6435547
    [No Abstract]   [Full Text] [Related]  

  • 80. Enteric transport of chlordecone (Kepone) in the rat.
    Bungay PM; Dedrick RL; Matthews HB
    J Pharmacokinet Biopharm; 1981 Jun; 9(3):309-41. PubMed ID: 6169822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.